NON-ONCOLOGY PRECISION MEDICINE MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: BYR-146165 |   Healthcare

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Non-Oncology Precision Medicine Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL NON-ONCOLOGY PRECISION MEDICINE MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL NON-ONCOLOGY PRECISION MEDICINE MARKET

7.1 GLOBAL NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA NON-ONCOLOGY PRECISION MEDICINE MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 Abbott Laboratories

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Agilent Technologies, Inc.

16.3 Almac Group Ltd.

16.4 Astra Zeneca

16.5 ASURAGEN INC.

16.6 BGI Group

16.7 Bio-Rad Laboratories, Inc.

16.8 bioMerieux S.A.

16.9 Bristol-Myers Squibb Company

16.10 Danaher Corporation

16.11 F. Hoffmann-La Roche Ltd

16.12 Gilead Sciences, Inc.

16.13 GlaxoSmithKline plc

16.14 Illumina, Inc.

16.15 Invitae Corporation

16.16 Konica Minolta, Inc.

16.17 Laboratory Corporation of America Holdings

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

By Application
Infectious Diseases
 o Respiratory Infections
 o Gastrointestinal Infections
 o Sexually Transmitted Infections
 o Others
Neurology
 o Neurodegenerative Disorders
 o Neuropsychiatric Disorders
 o Others
Cardiovascular
 o Cardiac Myopathies and Arrhythmia
 o Others
Lifestyle and Endocrinology
Gastroenterology
Other Applications

By Ecosystem
Applied Sciences
 o Genomics
 o By Technology
    o Polymerase Chain Reaction (PCR)
    o Precision Medicine Next-Generation Sequencing (PM NGS)
    o Genome Editing
    o Other Technologies
 o Pharmacogenomics
 o Other Applied Sciences
Precision Diagnostics
 o Molecular Diagnostics (MDx)
 o Medical Imaging
Digital Health and Information Technology
 o Clinical Decision Support Systems (CDSS)
 o Big Data Analytics
 o IT Infrastructure
 o Genomics Informatics
 o In-Silico Informatics
 o Mobile Health
Precision Therapeutics
 o Clinical Trials
 o Cell Therapy
 o Drug Discovery and Research
 o Gene Therapy

Companies

Abbott Laboratories
Agilent Technologies, Inc.
Almac Group Ltd.
Astra Zeneca
ASURAGEN INC.
BGI Group
Bio-Rad Laboratories, Inc.
bioMerieux S.A.
Bristol-Myers Squibb Company
Danaher Corporation
F. Hoffmann-La Roche Ltd
Gilead Sciences, Inc.
GlaxoSmithKline plc
Illumina, Inc.
Invitae Corporation
Konica Minolta, Inc.
Laboratory Corporation of America Holdings

Single User License  : 3900$
Corporate License    : 7800$
Enquiry Before Buying
Request For Customization
Speak To Analyst

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE

    • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY

    • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH

    • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING

    • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.